Nova Financial’s Neurocrine Biosciences NBIX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$7.09K Buy
+50
New +$8.04K ﹤0.01% 608

Other funds holding NBIX

Nova Financial's NBIX Position: Q3 2026 in Review

Nova Financial opened a new position in Neurocrine Biosciences (NBIX) in Q3 2026: 50 shares worth $7.09K. The stake represents ﹤0.01% of the portfolio and ranks #608 among its holdings.

766 funds tracked by Wall St. Rank hold NBIX as of Q3 2026.

  • Nova Financial held 50 shares of Neurocrine Biosciences worth $7.09K as of Q3 2026.
  • Neurocrine Biosciences was a new Nova Financial position in Q3 2026.
  • Neurocrine Biosciences made up ﹤0.01% of Nova Financial's portfolio in Q3 2026, its #608 holding.
  • 766 funds tracked by Wall St. Rank held Neurocrine Biosciences as of Q3 2026.

Based on Nova Financial's 13F filing for Q3 2026, filed 4 Nov 2026.